Description
A potent and selective CB2 receptor agonist, with 190-fold selectivity for CB2 over the CB1 receptor (Kis = 6.3 and 1,220 nM, respectively); 3 mg/kg induces analgesia in a formalin-induced nocifensive study in mice without cannabis-like behavioral effects; ameliorates insulin resistance in vivo and increases insulin secretion and accumulation in pancreatic islets isolated from HFD/STZ-induced diabetic mice
Formal name: 1,4-dihydro-6-(1-methylethyl)-4-oxo-1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-3-quinolinecarboxamide
Synonyms:
Molecular weight: 434.6
CAS: 1048038-90-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Neuroscience|Cannabinoid Research|CB1 & CB2 Receptors||Research Area|Neuroscience|Pain Research